|
1
|
Sircar K, Hewlett BR, Huizinga JD,
Chorneyko K, Berezin I and Riddell RH: Interstitial cells of Cajal
as precursors of gastrointestinal stromal tumors. Am J Surg Pathol.
23:377–389. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chan JK: Mesenchymal tumors of the
gastrointestinal tract: A paradise for acronyms (STUMP, GIST GANT,
and now GIPACT), implication of c-kit in genesis, and yet another
of the many emerging roles of the interstitial cell of Cajal in the
pathogenesis of gastrointestinal diseases? Adv Anat Pathol.
6:19–40. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rutkowski P, Debiec-Rychter M and Ruka W:
Gastrointestinal stromal tumors, Key to diagnosis and choice of
therapy. Mol Diagn Ther. 12:131–143. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rutkowski P, Wozniak A, Dębiec-Rychter M,
Kąkol M, Dziewirski W, Zdzienicki M, Ptaszynski K, Jurkowska M,
Limon J and Siedlecki JA: Clinical utility of the new American
Joint Committee on Cancer staging system for gastrointestinal
stromal tumors, Current overall survival after primary tumor
resection. Cancer. 117:4916–4924. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Corless CL, Fletcher JA and Heinrich MC:
Biology of gastrointestinal stromal tumors. J Clin Oncol.
22:3813–3825. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Miettinen M, Sarlomo-Rikala M and Lasota
J: Gastrointestinal stromal tumors, Recent advances in
understanding of their biology. Hum Pathol. 30:1213–1220. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Roberts PJ and Eisenberg B: Clinical
presentation of gastrointestinal stromal tumors and treatment of
operable disease. Eur J Cancer. 38((Suppl 5)): S37–S38. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Neuhaus SJ, Clark MA, Hayes AJ, Thomas JM
and Judson I: Surgery for gastrointestinal stromal tumour in the
post-imatinib era. ANZ J Surg. 75:165–172. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Duensing A, Heinrich MC, Fletcher CD and
Fletcher JA: Biology of gastrointestinal stromal tumors, KIT
mutations and beyond. Cancer Invest. 22:106–116. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Heinrich MC, Rubin BP, Longley BJ and
Fletcher JA: Biology and genetic aspects of gastrointestinal
stromal tumors, KIT activation and cytogenetic alterations. Hum
Pathol. 33:484–495. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huizinga JD, Thuneberg L, Klüppel M,
Malysz J, Mikkelsen HB and Bernstein A: W/kit gene required for
interstitial cells of Cajal and for intestinal pacemaker activity.
Nature. 373:347–349. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nannini M, Astolfi A, Urbini M, Indio V,
Santini D, Heinrich MC, Corless CL, Ceccarelli C, Saponara M,
Mandrioli A, et al: Integrated genomic study of quadruple-WT GIST
(KIT/PDGFRA/SDH/RAS pathway wild-type GIST). BMC Cancer.
14:6852014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pantaleo MA, Nannini M, Corless CL and
Heinrich MC: Quadruple wild-type (WT) GIST, Defining the subset of
GIST that lacks abnormalities of KIT, PDGFRA, SDH, or RAS signaling
pathways. Cancer Med. 4:101–103. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Heinrich MC, Griffith DJ, Druker BJ, Wait
CL, Ott KA and Zigler AJ: Inhibition of c-kit receptor tyrosine
kinase activity by STI 571, a selective tyrosine kinase inhibitor.
Blood. 96:925–932. 2000.PubMed/NCBI
|
|
15
|
Chandramohan K, Agarwal M, Gurjar G, Gatti
RC, Patel MH, Trivedi P and Kothari KC: Gastrointestinal stromal
tumour in Meckel's diverticulum. World J Surg Oncol. 5:502007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Khoury MG: 2nd andA ulicino MR:
Gastrointestinal stromal tumor (GIST) presenting in a Meckel's
diverticulum. Abdom Imaging. 32:78–80. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kosmidis C, Efthimiadis C, Levva S,
Anthimidis G, Baka S, Grigoriou M, Tzeveleki I, Masmanidou M,
Zaramboukas T and Basdanis G: Synchronous colorectal adenocarcinoma
and gastrointestinal stromal tumor in Meckel's diverticulum; an
unusual association. World J Surg Oncol. 7:332009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Thirunavukarasu P, Sathaiah M, Sukumar S,
Bartels CJ, Zeh H III, Lee KK and Bartlett DL: Meckel's
diverticulum - a high-risk region for malignancy in the ileum.
Insights from a population-based epidemiological study and
implications in surgical management. Ann Surg. 253:223–230. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gillio-Tos A, De Marco L, Fiano V,
Garcia-Bragado F, Dikshit R, Boffetta P and Merletti F: Efficient
DNA extraction from 25-year-old paraffin-embedded tissues, Study of
365 samples. Pathology. 39:345–348. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Forbes SA, Bindal N, Bamford S, Cole C,
Kok CY, Beare D, Jia M, Shepherd R, Leung K, Menzies A, et al:
COSMIC: Mining complete cancer genomes in the Catalogue of Somatic
Mutations in Cancer. Nucleic Acids Res. 39(Database): D945–D950.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Futreal PA, Coin L, Marshall M, Down T,
Hubbard T, Wooster R, Rahman N and Stratton MR: A census of human
cancer genes. Nat Rev Cancer. 4:177–183. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
de Castro Pérez I, de Cárcer G and
Malumbres M: A census of mitotic cancer genes: New insights into
tumor cell biology and cancer therapy. Carcinogenesis. 28:899–912.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Santarius T, Shipley J, Brewer D, Stratton
MR and Cooper CS: A census of amplified and overexpressed human
cancer genes. Nat Rev Cancer. 10:59–64. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Altermann E and Klaenhammer TR:
PathwayVoyager: Pathway mapping using the Kyoto Encyclopedia of
Genes and Genomes (KEGG) database. BMC Genomics. 6:602005.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Franceschini A, Szklarczyk D, Frankild S,
Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering
C, et al: STRING v9.1: Protein-protein interaction networks, with
increased coverage and integration. Nucleic Acids Res. 41(D1):
D808–D815. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nilsson B, Bümming P, Meis-Kindblom JM,
Odén A, Dortok A, Gustavsson B, Sablinska K and Kindblom LG:
Gastrointestinal stromal tumors, The incidence, prevalence,
clinical course, and prognostication in the preimatinib mesylate
era - a population-based study in western Sweden. Cancer.
103:821–829. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dematteo RP, Heinrich MC, El-Rifai WM and
Demetri G: Clinical management of gastrointestinal stromal tumors,
Before and after STI-571. Hum Pathol. 33:466–477. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tosoni A, Nicolardi L and Brandes AA:
Current clinical management of gastrointestinal stromal tumors.
Expert Rev Anticancer Ther. 4:595–605. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ruka W, Rutkowski P, Nowecki Z,
Nasierowska-Guttmejer A and Debiec-Rychter M: Other malignant
neoplasms in patients with gastrointestinal stromal tumors (GIST).
Med Sci Monit. 10:LE13–LE14. 2004.PubMed/NCBI
|
|
30
|
Rutkowski P, Nowecki ZI, Michej W,
Debiec-Rychter M, Woźniak A, Limon J, Siedlecki J, Grzesiakowska U,
Kakol M, Osuch C, et al: Risk criteria and prognostic factors for
predicting recurrences after resection of primary gastrointestinal
stromal tumor. Ann Surg Oncol. 14:2018–2027. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hirota S, Isozaki K, Moriyama Y, Hashimoto
K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M,
et al: Gain-of-function mutations of c-kit in human
gastrointestinal stromal tumors. Science. 279:577–580. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chompret A, Kannengiesser C, Barrois M,
Terrier P, Dahan P, Tursz T, Lenoir GM and Bressac-De Paillerets B:
PDGFRA germline mutation in a family with multiple cases of
gastrointestinal stromal tumor. Gastroenterology. 126:318–321.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kwon JE, Kang HJ, Kim SH, Lee YC, Hyung
WJ, Noh SH, Kim NK and Kim H: Pathological characteristics of
gastrointestinal stromal tumours with PDGFRA mutations. Pathology.
41:544–554. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Schaefer IM, Ströbel P, Cameron S, Beham
A, Otto C, Schildhaus HU and Agaimy A: Rhabdoid morphology in
gastrointestinal stromal tumours (GISTs) is associated with PDGFRA
mutations but does not imply aggressive behaviour. Histopathology.
64:421–430. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gunawan B, Bergmann F, Höer J, Langer C,
Schumpelick V, Becker H and Füzesi L: Biological and clinical
significance of cytogenetic abnormalities in low-risk and high-risk
gastrointestinal stromal tumors. Hum Pathol. 33:316–321. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Schoppmann SF, Vinatzer U, Popitsch N,
Mittlböck M, Liebmann-Reindl S, Jomrich G, Streubel B and Birner P:
Novel clinically relevant genes in gastrointestinal stromal tumors
identified by exome sequencing. Clin Cancer Res. 19:5329–5339.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wozniak A, Sciot R, Guillou L, Pauwels P,
Wasag B, Stul M, Vermeesch JR, Vandenberghe P, Limon J and
Debiec-Rychter M: Array CGH analysis in primary gastrointestinal
stromal tumors Cytogenetic profile correlates with anatomic site
and tumor aggressiveness, irrespective of mutational status. Genes
Chromosomes Cancer. 46:261–276. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Astolfi A, Nannini M, Pantaleo MA, Di
Battista M, Heinrich MC, Santini D, Catena F, Corless CL, Maleddu
A, Saponara M, et al: A molecular portrait of gastrointestinal
stromal tumors: An integrative analysis of gene expression
profiling and high-resolution genomic copy number. Lab Invest.
90:1285–1294. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lagarde P, Pérot G, Kauffmann A, Brulard
C, Dapremont V, Hostein I, Neuville A, Wozniak A, Sciot R,
Schöffski P, et al: Mitotic checkpoints and chromosome instability
are strong predictors of clinical outcome in gastrointestinal
stromal tumors. Clin Cancer Res. 18:826–838. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu CH, Chen TC, Chau GY, Jan YH, Chen CH,
Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, et al: Analysis of
protein-protein interactions in cross-talk pathways reveals CRKL
protein as a novel prognostic marker in hepatocellular carcinoma.
Mol Cell Proteomics. 12:1335–1349. 2013. View Article : Google Scholar : PubMed/NCBI
|
